OrthoGrid Systems received FDA 510(k) clearance to market the PhantomMSK™ intraoperative surgical imaging platform.
PhantomMSK provides correction for fluoroscopic distortion in multiple procedures, including direct anterior approach total hip arthroplasty, where it is designed to help restore native hip biomechanics with alignment considerations for leg length, femoral offset, cup inclination, femoral abduction, pelvic tilt, and pelvic obliquity.
OrthoGrid Systems will introduce PhantomMSK next month at AAOS.
Sources: OrthoGrid Systems, Inc.; ORTHOWORLD Inc.
OrthoGrid Systems received FDA 510(k) clearance to market the PhantomMSK™ intraoperative surgical imaging platform.
PhantomMSK provides correction for fluoroscopic distortion in multiple procedures, including direct anterior approach total hip arthroplasty, where it is designed to help restore native hip biomechanics with alignment...
OrthoGrid Systems received FDA 510(k) clearance to market the PhantomMSK™ intraoperative surgical imaging platform.
PhantomMSK provides correction for fluoroscopic distortion in multiple procedures, including direct anterior approach total hip arthroplasty, where it is designed to help restore native hip biomechanics with alignment considerations for leg length, femoral offset, cup inclination, femoral abduction, pelvic tilt, and pelvic obliquity.
OrthoGrid Systems will introduce PhantomMSK next month at AAOS.
Sources: OrthoGrid Systems, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.